At 23.2% CAGR, Asia Pacific Hair Transplant Market is Projected to be Worth US$ 3,358.64 Million by 2030, says Business Market Insights

According to Business Market Insights' research, the Asia Pacific hair transplant market was valued at US$ 631.14 million in 2022 and is expected to reach US$ 3,358.64 million by 2030, registering a CAGR of 23.2% from 2022 to 2030. Increasing incidences of hair loss and technological advancements in hair transplant surgery are among the critical factors attributed to the Asia Pacific hair transplant market expansion.

Several reasons, such as Telogen Effluvium (TE), drug side effects, tinea capitis, and alopecia areata, are responsible for hair loss. TE is a common type of hair loss caused due to severe infection and prolonged illness. For instance, according to an article published in the Journal of Medicine and Life, telogen effluvium is one of the effects of the COVID-19 pandemic. Medications and stressful circumstances brought on by COVID-19 have resulted in causing TE.

Increasing use of medications such as lithium, beta-blockers, warfarin, heparin, amphetamines, and levodopa (Atamet, Larodopa, Sinemet) can also result in hair loss. In addition, many cancer chemotherapy drugs, including doxorubicin, frequently result in rapid hair loss. Furthermore, fungal infection of the scalp is one of the major reasons for hair loss in children. According to an article published in PLOS ONE in 2023, yearly tinea capitis accounts for 25 to 30% of all infections. Alopecia areata (AA) is an autoimmune disease that causes hair loss. As per the article published in the Journal of the German Society of Dermatology, 40% of patients experience their first AA symptom by age 20, and 83-88% experience it for the first time by age 40. Thus, increasing incidences of hair loss due to various factors are boosting the market growth.

On the contrary, high cost of hair transplant procedures hurdles the growth of Asia Pacific hair transplant market.

Based on procedures, the Asia Pacific hair transplant market is bifurcated into surgical hair transplant procedures and non-surgical procedures. The non-surgical procedures segment held 57.5% share of Asia Pacific hair transplant market in 2022, amassing US$ 362.98 million. It is projected to garner US$ 1,895.63 million by 2030 to expand at 23.0% CAGR during 2022-2030. The surgical hair transplant procedures segment is sub segmented into Follicular Unite Strip Surgery (FUS), Follicular Unit Extraction (FUE), and other surgical procedures. The non-surgical procedures segment is sub segmented into platelet rich plasma non-surgical procedures, laser cap, and others.

In terms of site of transplantation, the Asia Pacific hair transplant market is categorized into scalp transplant, eyelash transplant, eyebrow transplant, beard/ moustache transplant, chest transplant, and others. The scalp transplant segment held 76.3% share of Asia Pacific hair transplant market in 2022, amassing US$ 481.26 million. It is projected to garner US$ 2,541.34 million by 2030 to expand at 23.1% CAGR during 2022-2030.

Based on country, the Asia Pacific hair transplant market has been categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Our regional analysis states that the Rest of Asia Pacific captured 25.9% share of Asia Pacific hair transplant market in 2022. It was assessed at US$ 163.15 million in 2022 and is likely to hit US$ 830.59 million by 2030, exhibiting a CAGR of 22.6% during 2022-2030.

Key players operating in the Asia Pacific hair transplant market are Advanced GroHair, Hairmax Inc, Nathan Skin & Hair Transplant Centre, and Yanhee Hospital, among others.



Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com